MiNK Therapeutics, Inc.
INKT
$10.72
$0.212.00%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 6.73M | 5.78M | 5.09M | 4.30M | 4.31M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -377.20K | 481.60K | 468.60K | 468.60K | 468.60K |
| Total Operating Expenses | 12.11M | 11.91M | 10.61M | 9.82M | 11.12M |
| Operating Income | -12.11M | -11.91M | -10.61M | -9.82M | -11.12M |
| Income Before Tax | -12.49M | -12.36M | -11.27M | -9.74M | -10.78M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -12.49 | -12.36 | -11.27 | -9.74 | -10.78 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -12.49M | -12.36M | -11.27M | -9.74M | -10.78M |
| EBIT | -12.11M | -11.91M | -10.61M | -9.82M | -11.12M |
| EBITDA | -11.93M | -11.71M | -10.39M | -9.61M | -10.90M |
| EPS Basic | -2.97 | -3.03 | -2.84 | -2.50 | -2.91 |
| Normalized Basic EPS | -1.77 | -1.81 | -1.69 | -1.54 | -1.82 |
| EPS Diluted | -2.97 | -3.03 | -2.84 | -2.50 | -2.91 |
| Normalized Diluted EPS | -1.77 | -1.81 | -1.69 | -1.54 | -1.82 |
| Average Basic Shares Outstanding | 17.08M | 16.35M | 15.86M | 15.59M | 15.09M |
| Average Diluted Shares Outstanding | 17.08M | 16.35M | 15.86M | 15.59M | 15.09M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |